This educational activity is designed for gastroenterologists, endocrinologists, surgeons, internists, clinical researchers, physician assistants, nurses and other healthcare providers involved and/or interested in the diagnosis, treatment, and management of patients with infl ammatory bowel disease (IBD). Learning Objectives Upon completion of this activity, participants should be able to:
Comment on signifi cant advances in IBD therapeutic options regarding the use of biologics and immunomodulators
Review state-of-the-art endoscopic and surgical techniques
Assess advantages and disadvantages of current pharmacological therapies for IBD
Discuss emerging genomic research developments in IBD
Describe evolving patient management and treatment strategies for complications in IBD, both intra- and extra-intestinal
Comment on the recommendations in IBD for optimal cancer surveillance
Review the optimal strategy options for the management of pediatric and adolescent patients
Discuss the most recent ECCO recommendations on vaccination in IBD patient populations
Improve patient care and disease management options based on case presentations led by clinical experts in IBD
Past Events
4th Annual European Conference: Perspectives in Inflammatory Bowel Diseases - 11-12 Jun 2010, Bella Center, Copenhagen, Denmark (2690)
Annual European Conference: Perspectives in Inflammatory Bowel Diseases 2026
Important
Please, check "Annual European Conference: Perspectives in Inflammatory Bowel Diseases" official website for possible changes, before making any traveling arrangements
